Pertuzumab
Indication: HER2-positive solid tumors
Interactive pertuzumab population PK simulator based on a two-compartment linear PopPK model with fixed 840/420 mg q3w and weight-based dosing.
Drug Overview
Clinical Context
- Molecular Target
- HER2
- Drug Class
- Monoclonal antibody
- Therapeutic Area
- Oncology
- Indication
- HER2-positive solid tumors
- Route of Administration
- IV infusion
Model Information
- Model Type
- 2-compartment PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Pertuzumab allows you to explore concentration-time profiles under different dosing scenarios. The underlying 2-compartment PopPK model characterizes the pharmacokinetics of this monoclonal antibody following iv infusion administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Pertuzumab PK simulator?
This is a free, interactive pharmacokinetic simulator for Pertuzumab used in HER2-positive solid tumors. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Pertuzumab belong to?
Pertuzumab is classified as a Monoclonal antibody that targets HER2. It is used in the Oncology therapeutic area.
What route of administration does this model simulate?
This simulator models IV infusion administration of Pertuzumab. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 2-compartment PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Open test
Prurigo nodularis and chronic pruritic conditions
Serplulimab (HLX10) Population PK Simulator
Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
5-FU A Tool for Predicting Pharmacokinetic–Pharmacodynamic/Toxicodynamic Responses
PopPK of Docetaxel
capecitabine
PBPK-PD of ADCs
Ready to Simulate?
Launch the Pertuzumab simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community